Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2006 Oct;33(10):604-9.
doi: 10.1097/01.olq.0000216029.00424.ae.

Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia

Affiliations
Multicenter Study

Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia

Dara Potter et al. Sex Transm Dis. 2006 Oct.

Abstract

Objectives: The objectives of this cross-sectional study were to determine correlates of syphilis seroprevalence among HIV-infected and -uninfected antenatal attendees in an African multisite clinical trial, and to improve strategies for maternal syphilis prevention.

Results: A total of 2,270 (86%) women were HIV-infected and 366 (14%) were HIV-uninfected. One hundred seventy-five (6.6%) were syphilis-seropositive (7.3% among HIV-infected and 2.6% HIV-uninfected women). Statistically significant correlates included geographic site (odds ratio [OR] = 4.5, Blantyre; OR = 3.2, Lilongwe; OR = 9.0, Lusaka vs. Dar es Salaam referent); HIV infection (OR = 3.3); age 20 to 24 years (OR = 2.5); being divorced, widowed, or separated (OR = 2.9); genital ulcer treatment in the last year (OR = 2.9); history of stillbirth (OR = 2.8, one stillbirth; OR = 4.3, 2-5 stillbirths); and history of preterm delivery (OR = 2.7, one preterm delivery).

Conclusion: Many women without identified risk factors were syphilis-seropositive. Younger HIV-infected women were at highest risk. Universal integrated antenatal HIV and syphilis screening and treatment is essential in sub-Saharan African settings.

PubMed Disclaimer

References

    1. Ament LA, Whalen E. Sexually transmitted diseases in pregnancy: Diagnosis, impact, and intervention. J Obstet Gynecol Neonatal Nurs. 1996;25:657–666. - PubMed
    1. Pao D, Goh BT, Bingham JS. Management issues in syphilis. Drugs. 2002;62:1447–1461. - PubMed
    1. Watson-Jones D, Changulacha J, Gumodoka B, et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis. 2002;186:940–947. - PubMed
    1. Finelli L, Berman SM, Koumans EH, et al. Congenital syphilis. Bull World Health Organ. 1998;76 suppl 2:126–128. - PMC - PubMed
    1. Brocklehurst P. Update on the treatment of sexually transmitted infections in pregnancy—1. Int J STD AIDS. 1999;10:571–580. - PubMed

Publication types

MeSH terms